ClinicalTrials.Veeva

Menu

Pulmonary Diffusing Capacity During Acute Exercise in Patients With COPD (DiffLung2)

Rigshospitalet logo

Rigshospitalet

Status

Enrolling

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Diagnostic Test: Acute exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT05583396
DiffLung2

Details and patient eligibility

About

The combined measurement of the pulmonary diffusing capacity to carbon monoxide (CO) and nitric oxide (NO) (DLCO/NO) during exercise may be a useful physiological measure of alveolar-capillary reserve in patients with Chronic obstructive pulmonary disease (COPD). The present study investigated the test-retest reliability of DLCO/NO-based metrics.

Full description

The combined measurement of the pulmonary diffusing capacity to carbon monoxide (CO) and nitric oxide (NO) (DLCO/NO) has recently been standardised and validated for clinical use. It is thus ideal for assessing acute changes in pulmonary diffusing capacity and its components during various physiological manoeuvres. These changes are thought to involve acute changes in pulmonary perfusion and are notably relevant for patients with chronic obstructive pulmonary disease (COPD), in which they may be related to exertional dyspnoea. The aim of the present study is to investigate the effects of acute exercise on pulmonary diffusing capacity, and to determine the day-to-day repeatability of such assessments.

Enrollment

15 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic obstructive pulmonary disease (GOLD II + III)

Exclusion criteria

  • Known heart disease
  • Pregnancy
  • Disease within two weeks prior to inclusion

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Acute exercise
Other group
Description:
Pulmonary diffusing capacity using the DLCO/NO technique is assessed at rest and during exercise (60% of maximal workload on a bicycle ergometer)
Treatment:
Diagnostic Test: Acute exercise

Trial contacts and locations

2

Loading...

Central trial contact

Ronan Berg, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems